Skip to Content
Current OncologyCurrent Oncology
  • Commentary
  • Open Access

1 October 2014

5 Pages

Hsp90 Inhibitors in Oncology: Ready for Prime Time?

and
Department of Oncology, Division of Medical Oncology, University of Calgary, and Tom Baker Cancer Centre, Calgary, AB, Canada
*
Author to whom correspondence should be addressed.

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

In the targeted oncology era, there has been a resurgence of interest in targeting members of the heat shock protein family, as evidenced by numerous ongoing trials in advanced malignancies (Table I).[...]

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.